Capecitabine (Cap) combined with bevacizumab (Bev) with or without vinorelbine (Vin) in first-line metastatic breast cancer (MBC): First safety results from the randomized CARIN trial

被引：3

作者：

Hegewisch-Becker, S.

Lerchenmuller, C. A.

Welt, A.

Decker, T.

Just, M.

Steffens, C.

Hipper, A.

Marschner, N.

机构：

[1] Private Practice Oncol, Hamburg, Germany

[2] Practice Oncol Hematol, Munster, Germany

[3] Univ Hosp Essen, West German Canc Ctr, Essen, Germany

[4] Onkol Ravensburg, Munster, Germany

[5] Private Practice Oncol, Bielefeld, Germany

[6] Private Practice Oncol, Niedersachsen, Germany

[7] IOMEDICO, Freiburg, Germany

[8] Med Practice Oncol & Hematol, Freiburg, Germany

来源：

关键词：

D O I：

10.1200/jco.2011.29.15_suppl.1044

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1044

引用

页数：1